Apex Kidney Care bags $9Mn funding from Blue Earth Capital AG
Summary
Apex Kidney Care, a dialysis service provider has raised $9 million funding in Foreign Direct Investment (FDI) from Blue Earth Capital AG for an undisclosed equity stake.The Tata Capital Healthcare Fund (TCHF) portfolio company plans to improve access to high-quality kidney care in India with the raised capital, according to a statement.TCHF made a similar equity investment in AKC last year, with an equal amount.Dr Shrirang Bichu, Co-founder of AKC, said, Together with TCHF and BlueEarth, we will continue our mission to expand and strengthen our comprehensive ecosystem for kidney disease patients. We remain committed to driving growth by enhancing accessibility. We will achieve this by collaborating with like-minded clinicians and hospitals, as well as partnering with government through PPP programs, with a strong focus on automation and quality.Established in 2008 by a group of five young nephrologists, Apex Kidney Care also provides home hemodialysis and other nephrology services, such as kidney transplants, peritoneal dialysis and consultations.With over 1,500 modern dialysis machines and more than 55,000 dialysis treatments each month, Apex has become one of Indias largest dialysis service providers and a top choice for quality care.Apex currently runs over 190 centers offering outpatient and inpatient dialysis services across 10 states, including Bihar, Delhi, Goa, Gujarat, Haryana, Madhya Pradesh, Maharashtra, Rajasthan, Telangana and Uttar Pradesh.Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:Startup Funding News: Your Gateway to Every Funding Update.Latest Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.